943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

2012 ◽  
Vol 142 (5) ◽  
pp. S-161 ◽  
Author(s):  
W.J. Sandborn ◽  
B.G. Feagan ◽  
C.W. Marano ◽  
R. Strauss ◽  
J. Johanns ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Induction Therapy ◽  
Blind Study ◽  
Double Blind Study ◽  
Active Ulcerative Colitis ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy

Sa1977 A Randomised, Double-Blind Study of High and Low Dose Oral Delayed-Release Mesalamine Does Not Demonstrate a Difference in Treating Mild to Moderately Active Ulcerative Colitis in Children

2012 ◽  
Vol 142 (5) ◽  
pp. S-371-S-372
Author(s):  
Harland S. Winter ◽  
Barbara Iwanczak ◽  
Melvin B. Heyman ◽  
Eduardo Ibarguen-Secchia ◽  
Maciej Kaczmarski ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Low Dose ◽  
Blind Study ◽  
Double Blind Study ◽  
Active Ulcerative Colitis ◽  
Double Blind ◽  
Delayed Release ◽  
Dose Oral

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study

2007 ◽  
Vol 39 (4) ◽  
pp. 329-337 ◽  
Author(s):  
L. Biancone ◽  
P. Gionchetti ◽  
G. Del Vecchio Blanco ◽  
A. Orlando ◽  
V. Annese ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Beclomethasone Dipropionate ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Distal Ulcerative Colitis
Sign in / Sign up

Export Citation Format

Share Document